作用于VEGF信号通路的血管生成抑制剂

被引:24
作者
万博
刘煜
机构
[1] 中国药科大学生化教研室
关键词
血管内皮细胞生长因子; 靶向治疗; 血管生成抑制剂;
D O I
暂无
中图分类号
R96 [药理学];
学科分类号
100706 [药理学];
摘要
分类介绍作用于血管内皮细胞生长因子信号通路的血管生成抑制剂研究近况以及该类药物存在的缺陷。血管生长促进因子和血管抑制因子的活性及其表达水平对肿瘤的发生和发展具有关键性的作用,所以,针对于血管生成,尤其是靶向于血管内皮细胞生长因子的药物已成为近年来抗肿瘤药物研究的热点之一。
引用
收藏
页码:256 / 263
页数:8
相关论文
共 9 条
[1]
Vascular endothelial growth factor antisense oligodeoxynucleotides with lipiodol in arterial embolization of liver cancer in rats [J].
Wu, Han-Ping ;
Feng, Gan-Sheng ;
Liang, Hui-Min ;
Zheng, Chuan-Sheng ;
Li, Xin .
WORLD JOURNAL OF GASTROENTEROLOGY, 2004, 10 (06) :813-818
[2]
The Role of VEGF Pathways in Human Physiologic and Pathologic Angiogenesis [J].
Lyons, John M., III ;
Schwimer, Joshua E. ;
Anthony, Catherine T. ;
Thomson, Jessica L. ;
Cundiff, Jason D. ;
Casey, Douglas T. ;
Maccini, Cynthia ;
Kucera, Paul ;
Wang, Yi-Zarn ;
Boudreaux, J. Philip ;
Woltering, Eugene A. .
JOURNAL OF SURGICAL RESEARCH, 2010, 159 (01) :517-527
[3]
COX-2, VEGF AND TUMOUR ANGIOGENESIS [J].
Toomey, D. P. ;
Murphy, J. F. ;
Conlon, K. C. .
SURGEON-JOURNAL OF THE ROYAL COLLEGES OF SURGEONS OF EDINBURGH AND IRELAND, 2009, 7 (03) :174-180
[4]
A potential role for reactive oxygen species and the HIF-1α–VEGF pathway in hypoxia-induced pulmonary vascular leak.[J].David C. Irwin;Joe. M. McCord;Eva Nozik-Grayck;Ginny Beckly;Ben Foreman;Tim Sullivan;Molly White;Joseph T. Crossno;Damian Bailey;Sonia C. Flores;Susan Majka;Dwight Klemm;Martha C. Tissot van Patot.Free Radical Biology and Medicine.2009, 1
[5]
Sequential Use of the Tyrosine Kinase Inhibitors Sorafenib and Sunitinib in Metastatic Renal Cell Carcinoma: A Retrospective Outcome Analysis [J].
Eichelberg, Christian ;
Heuer, Roman ;
Chun, Felix K. ;
Hinrichs, Kristin ;
Zacharias, Mario ;
Huland, Hartwig ;
Heinzer, Hans .
EUROPEAN UROLOGY, 2008, 54 (06) :1373-1378
[6]
siRNA targeting VEGF inhibits hepatocellular carcinoma growth and tumor angiogenesis in vivo [J].
Raskopf, Esther ;
Vogt, Annabelle ;
Sauerbruch, Tilman ;
Schrnitz, Volker .
JOURNAL OF HEPATOLOGY, 2008, 49 (06) :977-984
[7]
Reversible Posterior Leukoencephalopathy Syndrome in Cancer [J].
Vaughn, Christopher ;
Zhang, Louann ;
Schiff, David .
CURRENT ONCOLOGY REPORTS, 2008, 10 (01) :86-91
[8]
VEGF/VEGFR signalling as a target for inhibiting angiogenesis [J].
Kiselyov, Alex ;
Balakin, Konstantin V. ;
Tkachenko, Sergey E. .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2007, 16 (01) :83-107
[9]
The proportion of patients with metastatic non-small cell lung cancer potentially eligible for treatment with bevacizumab: A single institutional survey [J].
Velcheti, Vamsidhar ;
Viswanathan, Avinash ;
Govindan, Ramaswamy .
JOURNAL OF THORACIC ONCOLOGY, 2006, 1 (05) :501-501